Related Experiment Video
Updated: Jun 3, 2026

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
[Celiac disease in Emilia Romagna]
P Cacciari1, M T Montella, P Alvisi
1Dipartimento di Sanità Pubblica, Universitá degli Studi di Bologna. paolo.cacciari@unibo.it
Celiac disease prevalence is underestimated globally. This study in Emilia Romagna found 1.8 cases per 1000 people, with significant regional variation, confirming underdiagnosis worldwide.
Area of Science:
- Gastroenterology
- Epidemiology
- Public Health
Background:
- Celiac disease prevalence is often underestimated globally.
- Regional variations in diagnosis and reporting contribute to underestimation.
- Understanding local prevalence is crucial for public health initiatives.
Purpose of the Study:
- To estimate the prevalence of celiac disease in the Emilia Romagna region.
- To compare regional data with international celiac disease prevalence rates.
- To highlight the ongoing underestimation of celiac disease.
Main Methods:
- Analysis of symptomatic patients within the regional health service reimbursement program in 2008.
- Inclusion of 7811 patients in the study cohort.
- Examination of age-specific prevalence and district-level variations.
Main Results:
- Overall celiac disease prevalence in Emilia Romagna was 1.8 patients per 1000 citizens.
- Prevalence showed significant variability across districts, ranging from 1:384 in Parma to 1:909 in Piacenza.
- No significant age-related prevalence was observed, except possibly in infants aged 0-1, potentially linked to breastfeeding.
Conclusions:
- The study confirms the underestimation of celiac disease prevalence, consistent with findings in other countries.
- Despite diagnostic tools like serological tests and small bowel histology, underdiagnosis persists.
- A multidisciplinary approach is recommended to enhance celiac disease awareness and investigate its pathogenesis.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease
Other Disorders of Digestive System
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Gastritis II: Pathophysiology
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

